Abstract:Automated methods for prostate cancer (PCa) diagnosis in multi-parametric magnetic resonance imaging (MP-MRIs) are critical for alleviating requirements for interpretation of radiographs while helping to improve diagnostic accuracy (Artan et al 2010 IEEE Trans. Image Process. 19 2444-55, Litjens et al 2014 IEEE Trans. Med. Imaging 33 1083-92, Liu et al 2013 SPIE Medical Imaging (International Society for Optics and Photonics) p 86701G, Moradi et al 2012 J. Magn. Reson. Imaging 35 1403-13, Niaf et al 2014 IEEE Trans. Image Process. 23 979-91, Niaf et al 2012 Phys. Med. Biol. 57 3833, Peng et al 2013a SPIE Medical Imaging (International Society for Optics and Photonics) p 86701H, Peng et al 2013b Radiology 267 787-96, Wang et al 2014 BioMed. Res. Int. 2014). This paper presents an automated method based on multimodal convolutional neural networks (CNNs) for two PCa diagnostic tasks: (1) distinguishing between cancerous and noncancerous tissues and (2) distinguishing between clinically significant (CS) and indolent PCa. Specifically, our multimodal CNNs effectively fuse apparent diffusion coefficients (ADCs) and T2-weighted MP-MRI images (T2WIs). To effectively fuse ADCs and T2WIs we design a new similarity loss function to enforce consistent features being extracted from both ADCs and T2WIs. The similarity loss is combined with the conventional classification loss functions and integrated into the back-propagation procedure of CNN training. The similarity loss enables better fusion results than existing methods as the feature learning processes of both modalities are mutually guided, jointly facilitating CNN to 'see' the true visual patterns of PCa. The classification results of multimodal CNNs are further combined with the results based on handcrafted features using a support vector machine classifier. To achieve a satisfactory accuracy for clinical use, we comprehensively investigate three critical factors which could greatly affect the performance of our multimodal CNNs but have not been carefully studied previously. (1) Given limited training data, how can these be augmented in sufficient numbers and variety for fine-tuning deep CNN networks for PCa diagnosis? (2) How can multimodal MP-MRI information be effectively combined in CNNs? (3) What is the impact of different CNN architectures on the accuracy of PCa diagnosis? Experimental results on extensive clinical data from 364 patients with a total of 463 PCa lesions and 450 identified noncancerous image patches demonstrate that our system can achieve a sensitivity of 89.85% and a specificity of 95.83% for distinguishing cancer from noncancerous tissues and a sensitivity of 100% and a specificity of 76.92% for distinguishing indolent PCa from CS PCa. This result is significantly superior to the state-of-the-art method relying on handcrafted features.

Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI

Evaluation of a Cascaded Deep Learning-based Algorithm for Prostate Lesion Detection at Biparametric MRI

Deep Attentive Panoptic Model for Prostate Cancer Detection Using Biparametric MRI Scans

Deep Learning in Prostate Cancer Diagnosis Using Multiparametric Magnetic Resonance Imaging With Whole-Mount Histopathology Referenced Delineations

Fully Automated Deep Learning Model to Detect Clinically Significant Prostate Cancer at MRI

Computer-aided detection of prostate cancer in early stages using multi-parameter MRI: A promising approach for early diagnosis

Autonomous Detection and Classification of PI-RADS Lesions in an MRI Screening Population Incorporating Multicenter-Labeled Deep Learning and Biparametric Imaging: Proof of Concept

Computer‐aided Diagnosis of Prostate Cancer Using a Deep Convolutional Neural Network from Multiparametric MRI

Multimodal AI Combining Clinical and Imaging Inputs Improves Prostate Cancer Detection

Co-trained Convolutional Neural Networks for Automated Detection of Prostate Cancer in Multi-Parametric MRI.

Deep learning for fully automatic detection, segmentation, and Gleason grade estimation of prostate cancer in multiparametric magnetic resonance images

Multi-view radiomics and deep learning modeling for prostate cancer detection based on multi-parametric MRI

Automated Diagnosis of Prostate Cancer Using mpMRI Images: A Deep Learning Approach for Clinical Decision Support

Fully automated detection and localization of clinically significant prostate cancer on MR images using a cascaded convolutional neural network

Automated diagnosis of prostate cancer in multi-parametric MRI based on multimodal convolutional neural networks

Deep learning-based artificial intelligence for prostate cancer detection at biparametric MRI

Deep learning model for the detection of prostate cancer and classification of clinically significant disease using multiparametric MRI in comparison to PI-RADs score

Prostate Lesion Estimation using Prostate Masks from Biparametric MRI

Joint Detection and Diagnosis of Prostate Cancer in Multi-parametric MRI Based on Multimodal Convolutional Neural Networks

Automatic computer-aided detection of prostate cancer based on multiparametric magnetic resonance image analysis

Deep-Learning Models for Detection and Localization of Visible Clinically Significant Prostate Cancer on Multi-Parametric MRI